CS logo
small CS logo
UMHAT "Sv. Georgi", EAD

Plovdiv, Bulgaria
Hospital in Plovdiv
bulevard "Peshtersko Shose" 66, 4001 Western Industrial Zone, Plovdiv

About UMHAT "Sv. Georgi", EAD


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
6
Janssen Research & Development, LLC
5
Pfizer
5
Baxalta now part of Shire
4
Hoffmann-La Roche
4
AOP Orphan Pharmaceuticals AG
3
Agios Pharmaceuticals, Inc.
2
Daiichi Sankyo, Inc.
2
Forest Laboratories
2
Actelion
1
Amgen
1
Total Rows: 31

Clinical Trials at UMHAT "Sv. Georgi", EAD


During the past decade, UMHAT "Sv. Georgi", EAD conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 29 clinical trials were completed, i.e. on average, 72.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years5555111111774466117711004444443322Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
2006-09-04
2011-05-26
Completed
545
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma
2010-07-14
2017-12-05
Completed
792
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
2010-12-01
2015-01-01
Completed
146
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
2011-01-01
2012-05-01
Completed
143
Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B
2011-09-01
2014-04-01
Completed
25
An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin
2011-05-31
2014-07-31
Completed
443

Rows per page:

1–55 of 55

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UMHAT "Sv. Georgi", EAD" #1 sponsor was "Bayer" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Baxalta now part of Shire" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT "Sv. Georgi", EAD" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 6Bayer: 6Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Pfizer: 5Pfizer: 5Baxalta now part of Shire: 4Baxalta now part of Shire: 4Hoffmann-La Roche: 4Hoffmann-La Roche: 4AOP OrphanPharmaceuticals AG: 3AOP OrphanPharmaceuticals AG: 3Agios Pharmaceuticals, Inc.: 2Agios Pharmaceuticals, Inc.: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2Forest Laboratories: 2Forest Laboratories: 2Actelion: 1Actelion: 1

Created with Highcharts 11.1.0Top CollaboratorsBaxalta InnovationsGmbH, now part ofShire: 2Baxalta InnovationsGmbH, now part ofShire: 2Regeneron Pharmaceuticals: 2Regeneron Pharmaceuticals: 2Arena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1Brigham and Women'sHospital: 1Brigham and Women'sHospital: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Gilead Sciences: 1Gilead Sciences: 1LFB USA, Inc.: 1LFB USA, Inc.: 1PSI CRO: 1PSI CRO: 1PharmaEssentia (Co-Sponsor for USA): 1PharmaEssentia (Co-Sponsor for USA): 1PharmaEssentiaCorporation (for theU.S.): 1PharmaEssentiaCorporation (for theU.S.): 1

Clinical Trials Conditions at UMHAT "Sv. Georgi", EAD


According to Clinical.Site data, the most researched conditions in "UMHAT "Sv. Georgi", EAD" are "Hemophilia A" (4 trials), "Ulcerative Colitis" (3 trials), "Atrial Fibrillation" (2 trials), "Bipolar Disorder" (2 trials) and "Depression" (2 trials). Many other conditions were trialed in "UMHAT "Sv. Georgi", EAD" in a lesser frequency.

Clinical Trials Intervention Types at UMHAT "Sv. Georgi", EAD


Most popular intervention types in "UMHAT "Sv. Georgi", EAD" are "Drug" (44 trials), "Biological" (9 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Rituximab" (3 trials), "Standard of Care" (3 trials), "Bendamustine" (2 trials) and "Cariprazine" (2 trials). Other intervention names were less common.

Clinical Trials Genders at UMHAT "Sv. Georgi", EAD


The vast majority of trials in "UMHAT "Sv. Georgi", EAD" are 50 trials for "All" genders and 5 trials for "Male" genders.

Clinical Trials Status at UMHAT "Sv. Georgi", EAD


Currently, there are NaN active trials in "UMHAT "Sv. Georgi", EAD". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in UMHAT "Sv. Georgi", EAD, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in UMHAT "Sv. Georgi", EAD, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 38Phase 3: 38Phase 2: 10Phase 2: 10Phase 4: 3Phase 4: 3Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 33Completed: 33Recruiting: 10Recruiting: 10Active, not recruiting: 6Active, not recruiting: 6Terminated: 6Terminated: 6